• Without prejudice

    We all need to fight the ugly bigotry that’s made news recently, says Mandi Smallhorne.

  • Inside Labour

    The Davos extravaganza is slick PR and no UN-style institution, says Terry Bell.

  • 2015 Gadget preview

    Arthur Goldstuck presents gadgets to connect 2015 to the past and future.

Loading...
See More

Litha extends global reach

Feb 16 2011 14:29 I-Net Bridge

Related Articles

Litha Healthcare to acquire PharmAfrica

Litha posts healthy earnings rise

Litha takes aim with vaccines

Litha Healthcare acquires balance of shares

Litha Healthcare ups revenues

 
Johannesburg - Litha Healthcare Group [JSE:LHG], a JSE-listed company with operations in the pharmaceutical, medical devices and biotechnology sectors of the healthcare industry, on Wednesday said it had signed a deal with Cpoint Capital, a Canadian-based firm.

It is headed by Ian Jacobson.

"This agreement represents an exciting and significant step forward for the Litha Group and in particular our Litha pharma division," said group CEO Selwyn Kahanovitz.

Litha Healthcare Group's footprint includes pharmaceutical products, vaccines and medical devices. The tie-up is expected to help grow its pharmaceutical division.

Jacobson will join Litha Healthcare Group's board of directors as a non-executive member.
litha healthcare group

NEXT ON FIN24X

 

Latest Articles

15 Investment Tips for 2015 Read More...
Tax-free saving accounts are coming Read More...
Which generator is right for you? Read More...
5 top tips to help you save on your next grocery bill Read More...
 
 

Read Fin24’s Comments Policy

24.com publishes all comments posted on articles provided that they adhere to our Comments Policy. Should you wish to report a comment for editorial review, please do so by clicking the 'Report Comment' button to the right of each comment.

Comment on this story
0 comments
Add your comment
Comment 0 characters remaining
 

Company Snapshot

Money Clinic

Money Clinic
Do you have a question about your finances? We'll get an expert opinion.
Click here...
Loading...